Objective To explore the graft versus leukemia effects of donor lymphocyte infusion(DLI) after nonmyeloablative allogeneic bone marrow transplantation while attenuating treatment associated morbidity, mortality and graft versus host disease.
英
美
- 目的 探討非清除性異基因骨髓移植 (allo BMT)后供者淋巴細胞輸注 (DLI)是否能減少移植相關(guān)并發(fā)癥、相關(guān)死亡和減輕移植物抗宿主病 (GVHD) ,是否能增強移植物抗白血病 (GVL)效應。